Although ARG1 has been applied as a diagnostic biomarker for HCC, previous studies have reported that ARG1 serves as a biomarker of well-differentiated HCC [61, 62], and reduced ARG1 expression is associated with a poor prognostic phenotype [63]. The gene discussed is ARG1; the disease is hepatocellular carcinoma.